Bid | Ask | |
Price | 104.82% | 105.62% |
Volume | 500'000.00 | 500'000.00 |
Change compared with previous day | +0.03% | +0.03% |
Time | 05:15:00 | 05:15:00 |
Date | 07.03.2025 | 07.03.2025 |
Currency | CHF | |
Nominal amount | 1'000.00 | |
Exchange | SIX Structured Products | |
Life cycle | Secondary market |
Daily high/low | 105.66 / 104.78 |
All-time high/low | 105.28 / 100.07 |
Performance of structured product since issue | 5.22% |
Performance of underlying since issue | 19.32% |
Risk | |
SSPA VaR | n.a. |
SSPA risk rating | n.a. |
Volatility | |
30-day volatility | 0.93% |
100-day volatility | 0.93% |
Capital protection on expiry | 100.00% |
Strike | 10'958.90 (100%) |
Participation | 100.00% |
Barrier | 13'150.68 (120%) |
Distance to barrier | Hit |
Barrier touched | Yes |
Minimum repayment | 1'000.00 |
Maximum repayment | 1200 |
TER p.a. | n.a. |
ZKB Tracker-Zertifikat auf einen internationalen Dividendenbasket CHF 113975692 / CH1139756923 |
ZKB Autocallable Barrier Reverse Convertible on worst of Biogen Inc/BioNTech SE/Moderna Inc 132913422 / CH1329134220 |
ZKB Reverse Convertible auf Moderna Inc 135805451 / CH1358054513 |
ZKB Reverse Convertible on worst of BioNTech SE/Moderna Inc/Pfizer Inc 132912820 / CH1329128206 |
ZKB Reverse Convertible on worst of Eli Lilly & Co/Moderna Inc 135805731 / CH1358057318 |